Bridging Innovation to Better Healthcare Globally
OUR CORE SERVICES
We in-license and out-license high-quality finished dosage formulations manufactured in EUGMP, USFDA and PIC/s certified facilities across therapeutic categories, ensuring regulatory readiness, strong documentation support, and seamless commercialization in target international markets.
Strategic licensing of innovative, compliance-ready medical devices tailored for regulated and emerging markets, supported by technical documentation and commercialization alignment.
We evaluate market demand, competition, and regulatory pathways to structure product portfolios aligned with country-specific opportunities and long-term commercial scalability.
Comprehensive licensing agreements covering territory rights, exclusivity models, pricing frameworks, and lifecycle management to protect partner interests and maximize long-term value creation.
End-to-end formulation development for oral solids, injectables, and specialty dosage forms, optimized for stability, regulatory compliance, and efficient technology transfer.
Structured technology transfer processes ensuring smooth transition from pilot batches to commercial-scale production with validated documentation and quality control.
Robust validation protocols aligned with international regulatory standards to ensure consistent batch performance, data integrity, and global submission acceptance.
Scalable production capabilities offering flexible batch sizes, optimized cost structures, and reliable supply continuity for both emerging and regulated markets.
Our in-licensing decisions are guided by proprietary market intelligence and defined channel partner requirements, ensuring every product onboarded has validated demand, commercial logic, and reduced execution risk.
We structure commercialization through AuxoChem-owned or channel partner-owned brand models, optimizing market penetration, regulatory control, partner accountability, and long-term brand equity.
Our structured model aligns manufacturers, channel partners, and AuxoChem to ensure shared value creation, commercial transparency, sustainable margins, and scalable long-term partnerships across markets.
From compliant brand positioning and structured launch planning to performance optimization and portfolio expansion, we transform licensed products into sustainable, long-term revenue drivers.
About Us
Engineering Global Healthcare Partnerships
AuxoChem Private Limited is a globally oriented pharmaceutical and medical device services company headquartered in New Delhi, India. We specialize in in-licensing, out-licensing, Contract Manufacturing (CMO), and Contract Development & Manufacturing (CDMO) for finished pharmaceutical formulations and advanced medical devices.
By combining regulatory intelligence with world-class manufacturing partnerships, we act as a strategic bridge between innovation-driven manufacturers and high-growth international markets.
We don’t just supply products — we build compliant, scalable, and profitable global partnerships.
Global Standards. Zero Compromise.
Accelerating compliant market access across Southeast Asia, Africa, Latin America, CIS, and regulated markets worldwide.
OUR MISSION & VISION
At AuxoChem Private Limited, we believe healthcare should have no borders. Through ethical practices, scientific rigor, and an obsessive focus on quality and compliance, we are building a future where breakthrough therapies and life-saving solutions reach every corner of the world — faster, safer, and more affordably.
Mission
Vision
Why choose us
Your Strategic Advantage
Unmatched Regulatory Agility
Fast-track approvals across regulated and emerging markets.
Client-First Partnership Model
Transparent, responsive, long-term collaborations.
Speed & Scalability
From concept to commercial supply with optimized timelines.
End-to-End Manufacturing Excellence
Scalable CMO/CDMO solutions built for global standards.
Quality Without Compromise
Products meet or exceed global pharmacopeial benchmarks.
Global Footprint
Proven track record across Southeast Asia, Africa, Latin America, and CIS regions.